id | C00002218 |
---|---|
Name | Cytisine / (-)-Cytisine |
CAS RN | 485-35-8 |
Standard InChI | InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2 |
Standard InChI (Main Layer) | InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2 |
Phytochemical cluster | No. 3 |
---|---|
KCF-S cluster | No. 376 |
By standard InChI | CHEMBL47039 |
---|---|
By standard InChI Main Layer | CHEMBL47039 CHEMBL497939 CHEMBL1628606 |
By LinkDB | C10763 |
---|
By CAS RN | C004712 |
---|
class name | count |
---|---|
rosids | 45 |
eudicotyledons | 1 |
asterids | 1 |
family name | count |
---|---|
Fabaceae | 44 |
Convolvulaceae | 1 |
Viscaceae | 1 |
Anacardiaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL497939 |
CHEMBL1741321
(2)
|
1 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL47039 |
CHEMBL1738312
(1)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL497939 |
CHEMBL1613818
(1)
|
6 / 4 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL497939 |
CHEMBL1614544
(1)
|
11 / 10 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL497939 |
CHEMBL1741325
(2)
|
0 / 1 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | CHEMBL497939 CHEMBL1628606 |
CHEMBL838764
(1)
CHEMBL839749
(1)
CHEMBL826912 (1) CHEMBL826914 (3) CHEMBL826916 (3) CHEMBL885360 (1) CHEMBL908428 (1) CHEMBL950042 (1) CHEMBL1629178 (1) CHEMBL2343668 (1) |
0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | CHEMBL497939 |
CHEMBL838764
(1)
CHEMBL839749
(1)
CHEMBL839756 (1) CHEMBL826913 (1) CHEMBL826914 (3) CHEMBL827782 (1) CHEMBL885360 (1) CHEMBL908428 (1) CHEMBL950042 (1) CHEMBL2343668 (1) |
1 / 0 |
Q07001 | Acetylcholine receptor subunit delta | CHRN delta | CHEMBL497939 |
CHEMBL834065
(1)
CHEMBL825304
(1)
CHEMBL872144 (1) |
3 / 2 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | CHEMBL497939 CHEMBL1628606 |
CHEMBL754719
(1)
CHEMBL838862
(1)
CHEMBL826915 (2) CHEMBL826916 (3) CHEMBL827784 (1) CHEMBL835515 (1) CHEMBL835265 (1) CHEMBL838016 (1) CHEMBL825420 (1) CHEMBL876279 (1) CHEMBL874315 (1) CHEMBL882470 (1) CHEMBL883060 (1) CHEMBL883777 (1) CHEMBL908427 (1) CHEMBL1629209 (1) CHEMBL1629178 (1) |
1 / 1 |
P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | CHEMBL497939 |
CHEMBL834065
(1)
CHEMBL825304
(1)
CHEMBL872144 (1) |
2 / 1 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | CHEMBL497939 CHEMBL1628606 |
CHEMBL754719
(1)
CHEMBL838862
(1)
CHEMBL839756 (1) CHEMBL826913 (1) CHEMBL826915 (2) CHEMBL827782 (1) CHEMBL827784 (1) CHEMBL835515 (1) CHEMBL835265 (1) CHEMBL838016 (1) CHEMBL825420 (1) CHEMBL876279 (1) CHEMBL874315 (1) CHEMBL882470 (1) CHEMBL883060 (1) CHEMBL883777 (1) CHEMBL908427 (1) CHEMBL1629209 (1) |
1 / 1 |
P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | CHEMBL497939 |
CHEMBL834065
(1)
CHEMBL825304
(1)
CHEMBL872144 (1) |
3 / 2 |
P11230 | Acetylcholine receptor subunit beta | CHRN beta | CHEMBL497939 |
CHEMBL834065
(1)
CHEMBL825304
(1)
CHEMBL872144 (1) |
2 / 1 |
O75496 | Geminin | Unclassified protein | CHEMBL47039 |
CHEMBL2114780
(1)
|
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL47039 |
CHEMBL1794401
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL497939 |
CHEMBL1794467
(1)
|
0 / 0 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | CHEMBL497939 |
CHEMBL750438
(1)
CHEMBL839695
(1)
CHEMBL830100 (1) CHEMBL885367 (1) |
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL497939 |
CHEMBL1741322
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL497939 |
CHEMBL1741323
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL47039 CHEMBL497939 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (2) |
0 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL497939 |
CHEMBL1614250
(1)
|
4 / 3 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL47039 CHEMBL497939 |
CHEMBL1613914
(4)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL497939 |
CHEMBL1614531
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL497939 |
CHEMBL1614531
(1)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL47039 |
CHEMBL1613933
(1)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL47039 |
CHEMBL1613933
(1)
|
1 / 6 |
Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | CHEMBL497939 |
CHEMBL826912
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C004712 | 1135 |
CHRNA2
|
cholinergic receptor, nicotinic, alpha 2 (neuronal) | cytisine results in increased activity of [CHRNB4 protein binds to CHRNA2 protein] |
affects binding
/ increases activity |
protein |
9454827
|
C004712 | 1136 |
CHRNA3
LNCR2 NACHRA3 PAOD2 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) | cytisine results in increased activity of [CHRNB4 protein binds to CHRNA3 protein] |
affects binding
/ increases activity |
protein |
9454827
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | cytisine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
/ increases activity |
protein |
20331614
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | cytisine binds to [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
|
protein |
9336329
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
14645658
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | cytisine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
/ increases activity |
protein |
14645658
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | cytisine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein] |
affects binding
/ increases activity |
protein |
9454827
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
9336329
|
C004712 | 1137 |
CHRNA4
BFNC EBN EBN1 NACHR NACHRA4 NACRA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) | pozanicline inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
9336329
|
C004712 | 1139 |
CHRNA7
CHRNA7-2 NACHRA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) | cytisine inhibits the reaction [Bungarotoxins binds to CHRNA7 protein] |
affects binding
/ decreases reaction |
protein |
10216184
|
C004712 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | cytisine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
/ increases activity |
protein |
20331614
|
C004712 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | cytisine binds to [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
|
protein |
9336329
|
C004712 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
14645658
|
C004712 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | cytisine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein] |
affects binding
/ increases activity |
protein |
14645658
|
C004712 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
9336329
|
C004712 | 1141 |
CHRNB2
EFNL3 nAChRB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) | pozanicline inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]] |
affects binding
/ decreases reaction |
protein |
9336329
|
C004712 | 1143 |
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal) | cytisine results in increased activity of [CHRNB4 protein binds to CHRNA2 protein] |
affects binding
/ increases activity |
protein |
9454827
|
C004712 | 1143 |
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal) | cytisine results in increased activity of [CHRNB4 protein binds to CHRNA3 protein] |
affects binding
/ increases activity |
protein |
9454827
|
C004712 | 1143 |
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal) | cytisine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein] |
affects binding
/ increases activity |
protein |
9454827
|
OMIM | preferred title | UniProt |
---|---|---|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#265000 | Multiple pterygium syndrome, escobar variant; evmps |
P07510
|
#253290 | Multiple pterygium syndrome, lethal type; lmps |
P02708
P07510 Q07001 |
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency |
P11230
|
#608930 | Myasthenic syndrome, congenital, fast-channel |
P02708
Q07001 |
#601462 | Myasthenic syndrome, congenital, slow-channel; sccms |
P02708
P11230 Q07001 |
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P32297
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00770 | Congenital myasthenic syndrome |
P02708
(related)
P11230 (related) Q07001 (related) |
H00986 | Multiple pterygium syndrome |
P02708
(related)
P07510 (related) Q07001 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|